WO2006121522A3 - Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions - Google Patents
Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions Download PDFInfo
- Publication number
- WO2006121522A3 WO2006121522A3 PCT/US2006/011726 US2006011726W WO2006121522A3 WO 2006121522 A3 WO2006121522 A3 WO 2006121522A3 US 2006011726 W US2006011726 W US 2006011726W WO 2006121522 A3 WO2006121522 A3 WO 2006121522A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pumps
- therapeutic compositions
- implantable sensors
- scarring agents
- scarring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
Abstract
Pumps and sensors for contact with tissue are used in combination with an anti-scarring agent or a composition that comprises an anti-scarring agent to inhibit scarring that may otherwise occur when the pumps and sensors are implanted within an animal.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67929105P | 2005-05-10 | 2005-05-10 | |
US67929305P | 2005-05-10 | 2005-05-10 | |
US60/679,291 | 2005-05-10 | ||
US60/679,293 | 2005-05-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006121522A2 WO2006121522A2 (en) | 2006-11-16 |
WO2006121522A3 true WO2006121522A3 (en) | 2008-05-02 |
Family
ID=37397029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/011726 WO2006121522A2 (en) | 2005-05-10 | 2006-03-31 | Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006121522A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009052376A1 (en) | 2007-10-18 | 2009-04-23 | Musc Foundation For Research Development | Methods for the diagnosis of genitourinary cancer |
US9517023B2 (en) * | 2009-06-01 | 2016-12-13 | Profusa, Inc. | Method and system for directing a localized biological response to an implant |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
TWI657085B (en) | 2013-10-04 | 2019-04-21 | 英菲尼提製藥股份有限公司 | Heterocyclic compounds and uses thereof |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
JP6701088B2 (en) | 2014-03-19 | 2020-05-27 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | Heterocyclic compounds for use in the treatment of PI3K-gamma mediated disorders |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
KR20180058741A (en) | 2015-09-14 | 2018-06-01 | 인피니티 파마슈티칼스, 인코포레이티드 | Solid form of isoquinolines, a process for their preparation, compositions comprising them and methods for using them |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
TWI808055B (en) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Combination therapies of hdac inhibitors and pd-1 inhibitors |
TWI794171B (en) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Combination therapies of hdac inhibitors and pd-l1 inhibitors |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871351A (en) * | 1984-09-28 | 1989-10-03 | Vladimir Feingold | Implantable medication infusion system |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
-
2006
- 2006-03-31 WO PCT/US2006/011726 patent/WO2006121522A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871351A (en) * | 1984-09-28 | 1989-10-03 | Vladimir Feingold | Implantable medication infusion system |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
Also Published As
Publication number | Publication date |
---|---|
WO2006121522A2 (en) | 2006-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007041584A3 (en) | Implantable sensors, implantable pumps, and anti-scarring drug combinations | |
WO2006121522A3 (en) | Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions | |
WO2007041463A3 (en) | Electrical devices and anti-scarring drug combinations | |
WO2006121518A3 (en) | Electrical devices, anti-scarring agents, and therapeutic compositions | |
WO2006055008A3 (en) | Implantable sensors and implantable pumps and anti-scarring agents | |
WO2006009987A3 (en) | Dissolvable film composition | |
WO2007089864A3 (en) | Sutures and fibrosing agents | |
WO2007073486A3 (en) | Methods and compositions for delivering active agents with enhanced pharmacological properties | |
WO2006052451A3 (en) | Implantable collagen compositions | |
WO2005065079A3 (en) | Medical implants and fibrosis-inducing agents | |
WO2008033300A3 (en) | Bis (thiohydrazide amides) formulation | |
WO2007022344A3 (en) | Methods and compositions for the preventioin and treatment of kidney disease | |
WO2005123094A3 (en) | Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones | |
SI1909843T1 (en) | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field | |
WO2003061593A3 (en) | Novel targeted compositions for diagnostic and therapeutic use | |
WO2008136869A3 (en) | Methods and compositions related to targeting wounds, regenerating tissue, and tumors | |
WO2006089114A3 (en) | Methods and compositions for treating an anthrax toxin mediated condition | |
WO2007146983A3 (en) | Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury | |
WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
WO2005094554A3 (en) | Therapeutic agents, methods, and treatments | |
WO2007127333A3 (en) | Compositions for the treatment and prevention of eyelid swelling | |
WO2008010991A3 (en) | Methods and compositions for the treatment of cancer | |
WO2006099232A3 (en) | Antimicrobial pet wipes | |
WO2006056696A3 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
WO2007095258A3 (en) | Rhamnolipid compositions and related methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06748963 Country of ref document: EP Kind code of ref document: A2 |